CHAPTER 37 Managing wounds in palliative care
1. Distinguish between palliative and hospice care.
2. List types of wounds common to palliative care
3. Describe the possible etiologies of a malignant cutaneous wound and clinical manifestations.
5. List at least four goals in the management of a fungating wound in palliative care.
6. Describe at least four interventions used to achieve the goals associated with palliative wound care.
7. Explain the difference in debridement of a nonmalignant necrotic wound compared to debridement of a malignant cutaneous wound.
8. Identify at least four categories of dressings common in the care of the malignant cutaneous wound.
Definition of terms
Palliative care is an approach to care that is patient and family centered. Through the anticipation, prevention, and relief of suffering, palliative care optimizes quality of life. Physical, intellectual, psychosocial, and spiritual needs are addressed in palliative care to facilitate patient autonomy, informed decision making, and choice (National Quality Forum [NQF], 2006; World Health Organization [WHO], 2008). Palliative care is not synonymous with the abandonment of hope or treatment options. No specific therapies are excluded if they can improve the patient’s quality of life (Alvarez et al, 2002; Stephen-Haynes, 2008). In fact, palliative care is ideally a general approach to patient care that should be routinely integrated into primary care and should occur concurrently with other treatments. Specifically, palliative care is indicated for patients with a life-threatening or debilitating illness that encompasses a broad range of diagnoses, including people who are living with a persistent or recurring illness that adversely affects their daily functioning or will predictably reduce life expectancy (National Consensus Project for Quality Palliative Care, 2009). Palliative care focuses on the palliative journey from diagnosis onward rather than focusing on the last days of life (Morgan, 2009; Stephen-Haynes, 2008). Therefore, palliative care services are indicated across the trajectory of a patient’s illness and are not restricted to the end-of-life phase (NQF, 2006). Specialists in palliative care, those who have received formal education in palliative care and are credentialed in the field, may be consulted to provide specialty-level palliative care when the complexity of the situation warrants (National Consensus Project for Quality Palliative Care, 2009).
Hospice care is similar to palliative care in that the goals are to alleviate symptoms and improve quality of life. However, hospice is appropriate when life expectancy is 6 months or less. When the patient enters the terminal stage of an illness or condition, curative treatments are no longer effective, and/or the patient no longer desires to continue them, hospice becomes the care of choice. Hospice provides comprehensive biomedical, psychosocial, and spiritual support as patients face the end of life (American Academy of Hospice and Palliative Medicine [AAHPM] 2008; NQF, 2006). The key difference between palliative care and hospice is that palliative care is appropriate regardless of the stage of the disease or the need for other therapies and can be rendered along with life-prolonging treatment as the main focus of care (Malloy et al, 2008).
Palliative wound care
Palliative wound care has been defined as the “incorporation of strategies that prioritize symptomatic relief and wound improvement ahead of wound healing” (Alvarez et al, 2007). The focus of palliative wound care is the management of symptoms such as odor, exudate, bleeding, pain, and infection, and maintenance of skin integrity. Prevention of wound deterioration is desirable but is not always realistic, as with a fungating wound (Maund, 2008; Naylor, 2005; Stanley et al, 2008). Palliative care is elected care rather than care that is forced upon the patient; it focuses on physical, psychosocial, and spiritual issues during end of life (Hughes et al, 2005).
Indications
1. The patient is terminally ill. Most often this is a patient who has cancer, but it could just as well be a patient who has end-stage renal disease or significant congestive heart failure. The wound could be an open surgical wound, pressure ulcer, a burn, radiation dermatitis, etc.
2. Overwhelming comorbidities are present. As an example, a patient may have significant hypotension following a massive cardiac arrest and require high doses of a vasopressor medication to achieve an adequate blood pressure. The resulting vasoconstriction may be sufficient enough to cause a gradual transition in the finger tips or toes to cyanosis and then necrosis. Clearly the comorbidities dictate that the priority is sustaining adequate blood pressure.
3. Patient choice. This is the situation where a patient does not have overwhelming comorbidities or a terminal illness yet simply chooses palliation as a goal. Possible reasons may include a preference to continue a certain lifestyle that jeopardizes wound healing, a realization that the modifications needed for treatment are not feasible or consistent with other priorities, a financial burden, or a decision based on the patient’s age.
Nonmalignancy-related wounds
Any type of wound can be observed in a patient receiving palliative or hospice care. Some of the most common include pressure ulcers, skin stripping, and chemical dermatitis with co-existing pressure ulcers, which is perhaps the most common (Naylor 2005; Stephen-Haynes, 2008; Richards et al, 2007). Galvin (2002) reports that of all the ulcers that developed in the palliative care unit, 78.4% were sacral pressure ulcers.
The frequency of pressure ulcers in the patient receiving palliative care is varied, with an incidence reported as high as 43% (Walding, 2005). Galvin (2002) found 26.1% of patients admitted to a palliative care program over a 2-year time frame had a pressure ulcer, and 12% of all patients admitted to the palliative care setting developed a pressure ulcer during the stay. Within hospice programs, the literature reports an incidence of pressure ulcers ranging from 10% to 17.5%; prevalence is reported at 27% (Reifsnyder and Magee, 2005; Tippett, 2005). In a small study of a hospice program, a total of 35% of patients had some type of skin issue, 50% of them being pressure ulcers (Tippett, 2005).
Pressure ulcer prevention
Pressure ulcer prevention is an important component of palliative care (McGill and Chaplin, 2002). In a study of 980 home hospice patients, Reifsnyder and Magee (2005) reported 10% of patients developed a new pressure ulcer within the first 3 months of admission to the program. Of interest, however, in a survey of inpatient palliative care units, only 61% had a written policy for pressure ulcer prevention, 17.6% indicated their policy was under development, and 19.6% reported they did not have a policy. A pressure ulcer prevention program has been presented in detail in Chapters 8 and 9. In the palliative care setting, risk assessment and prevention have a few unique considerations.
Risk assessment.
International guidelines recommend pressure ulcer risk assessment for palliative care patients on a regular basis using a structured consistent approach (National Pressure Ulcer Advisory Panel [NPUAP] and European Pressure Ulcer Advisory Panel [EPUAP], 2009). Rather than assessing pressure ulcer risk solely by completing a risk assessment tool, they also recommend using a validated risk assessment tool, a comprehensive skin assessment, and clinical judgment with regard to key risk factors. Pressure ulcer risk assessment can be obtained using the Braden risk assessment form (Reifsnyder and Magee, 2005), the Hunters Hill pressure ulcer risk assessment tool specifically for the individual at or near the end of life (Chaplin, 2000; McGill and Chaplin, 2002), or the Waterloo risk assessment tool. In contrast, many experts suggest that every palliative care patient should be considered at “high risk” for pressure ulcer development (Richards et al, 2007; Walding, 2005).
Factors that contribute to pressure ulcer formation in palliative care patients include fragile skin condition, older age, decreasing food and fluid intake, altered sensation, poor general physical condition, and lean body constitution (Chaplin, 1999; Henoch and Gustaffson, 2003; Naylor and McGill, 2005). Of interest, Brink et al (2006) found that patients who used an indwelling urinary catheter or had an ostomy were more than four times more likely to develop one or more ulcers. Additional unique variables associated with pressure ulcer formation included new pain site, shortness of breath, and inability to lie flat (Brink et al, 2006). One fourth of all palliative home care patients experienced the inability to lie flat because of shortness of breath, which increased the patient’s risk of pressure ulcer formation. Decreased mobility, unrelieved pain, lack of appetite, and muscle wasting are other risk factors for pressure ulcer development in the palliative care patient (Liao and Arnold, 2007; Morgan, 2009; Walding, 2005). Risk assessment should be obtained within 6 to 12 hours of admission and should be reassessed on a daily basis because of the speed with which the palliative patient’s condition can change (McGill and Chaplin, 2002).
Prevention.
Pressure ulcer prevention interventions are vital for the palliative care patient population, particularly because the development and resulting treatment often are painful (Eisenberger and Zeleznik, 2004). At the same time, the pressure ulcer prevention plan of care must be reflective of and consistent with the patient’s clinical picture and end-of-life goals. Reducing or eliminating some risk factors may not be achievable or in accordance with the comfort-focused goals of palliative care (Reifsnyder and Magee, 2005). For example, maintaining the head of bed lower than 30 degrees or turning the patient every 2 hours may not be realistic or consistent with the patient’s wishes. In these instances, complete patient and family education becomes more critical than ever so that the patient and family are fully informed before they make decisions that may lead to pressure ulcer development. At the same time, it is the responsibility of the wound care provider to recommend the support surface that would best redistribute coccyx pressure while accommodating the patient’s need for an elevated head of bed. The international pressure ulcer treatment guidelines (NPUAP-EPUAP, 2009) instruct the care provider to consider changing the support surface to improve pressure redistribution and comfort.
Prevention measures that are most universally appropriate in palliative care include (1) adequate and appropriate offloading with a support surface, (2) adequate pain control for optimal positioning, and (3) incontinence management (containment and skin protection). However, good pain management is critical to being able to provide these basic prevention interventions (Liao and Arnold, 2007). The NPUAP-EPUAP 2009 guidelines stipulate the patient should be premedicated 20 to 30 minutes prior to a scheduled position change when he or she experiences significant pain with movement.
Whether all pressure ulcers that occur in palliative care patients are preventable or whether some are inevitable is not clear (Chaplin, 2004). Debate is growing about the possibility that as death approaches the skin begins to fail, primarily because of altered perfusion, which puts the patient at risk for further breakdown (Stanley et al, 2008). Richards et al (2007) reported that among a group of 61 end-of-life patients in palliative care, 8 of 13 new ulcers developed within 2 weeks of the patient’s death. In another study of palliative care wounds, nearly half of the pressure ulcers healed despite short treatment periods, underscoring the point that palliative wound care measures resulted in significant healing. However, regardless of the outcome of this debate, it is incumbent upon the wound specialist to provide care that is compliant with national guidelines for the prevention of pressure ulcers. Furthermore, documentation should record the implementation of assessments and interventions reflective of the guidelines as well as when interventions were withheld and why. A nosocomial pressure ulcer then can be considered inevitable when it develops even though the care provided met the standard of care for pressure ulcer prevention.
Pressure ulcer care
Pressure ulcer care in the palliative care patient should closely follow the international guidelines on pressure ulcer treatment and deviate from that standard only as needed and indicated in the 2009 Pressure Ulcer Management in Individuals Receiving Palliative Care section of the international guidelines (NPUAP-EPUAP, 2009). Overall, the palliative care guideline encourages comfort, prompt symptom management, consistency between care provided and the patient’s goals, and change guided by the values and goals of the patient and family (NPUAP-EPUAP, 2009). Specific and unique issues relative to exudate control, pain control, odor control, debridement, assessment and monitoring of healing, and dressing selection are discussed later in this chapter.
Malignancy-related wounds
Malignancy-related wounds can be a primary cutaneous tumor, a metastasis, or a malignant transformation of an existing ulcer. The common primary cutaneous tumors that can present as a wound are untreated basal cell cancer (Plate 71), squamous cell cancer, and malignant melanoma (Gerlach, 2005). A primary tumor also can invade up into the skin and erode through the skin to form a malignant wound (Hampton, 2008). Although any tumor left untreated can cause a malignant wound, the most common cancers are breast and soft tissue sarcoma (Naylor, 2002). A tumor can metastasize to the skin when it has invaded blood or lymph vessels; consequently, circulating malignant cells become trapped in the tiny skin capillaries. Seeding of malignant cells can occur during surgery to the abdominal wall, for example. Cancer of the ovary, cecum, and rectum can infiltrate the anterior wall of the abdomen (Grocott, 2007).
Malignant cutaneous wounds
Collectively, any wound that is a primary or metastatic skin lesion is referred to as a malignant cutaneous wound, also commonly known as a fungating malignant wound (Plate 70). These malignant cutaneous wounds usually are chronic, ulcerating, open, and draining (Bauer and Gerlach, 2000; Moore, 2002)
A malignant cutaneous wound begins as a small firm nodule under the surface of the skin that may be flesh colored, pink, red, violet, or brown (Gerlach, 2005; Naylor, 2002). As the malignant cells proliferate, they interfere with the capillaries and lymph vessels. While the tumor develops its own microcirculation, it is disorganized and has impaired blood clotting abilities (Naylor, 2002). These lesions can develop into necrotic “cauliflower-like” eruptions on the skin that progress to exudative and hemorrhagic wounds. Anaerobic organisms (usually Bacteroides) flourish on the necrotic tissue and produce volatile fatty acids as metabolic end-products that are responsible for the characteristic pungent and penetrating odor; this odor is a source of great embarrassment and distress to the patient, family, and caregivers (Draper, 2005; Piggin, 2003). The patient with malignant cutaneous wound may have no symptoms or may experience pruritus, pain, stinging, exudate, odor, and thickening and hardening of the skin (Moore, 2002; Seaman, 2006).
Malignant cutaneous wounds are often misinterpreted initially as an ulcer with an etiology of pressure, arterial insufficiency, or pyoderma. When the wound fails to progress despite appropriate topical therapy, cancer should be suspected and biopsies obtained from at least four different locations in the base of the wound. These kinds of wounds will appear abnormal (e.g., thickened, rolled wound edges) and should be thoroughly assessed (Gerlach, 2005).